FKBP4 and Alzheimer disease: The aim of this research is to screen for potential non-amyloid-beta-centric leads from traditional Chinese medicine targeting FKBP52 and to investigate its mechanisms with the hope of providing important insights for forwarding Alzheimer's disease.